...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Clinical trials query results

Go here: https://clinicaltrials.gov/

In Other terms field, search for "Zenith Epigenetics" or search for "ZEN-3694"

You will find all the currently listed trials. FYI, Xtandi=Enzalutamide and Keytruda=Pembrolizumab

Share
New Message
Please login to post a reply